Mark A. Kay

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Frederic Chereau, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark A. Kay:

Company Role Class Num Shares Value Price $ Report Date Ownership
LogicBio Therapeutics, Inc. Director Common Stock 0 $2.01 16 Nov 2022 Direct
LogicBio Therapeutics, Inc. Director Stock Option (right to buy) 0 16 Nov 2022 Direct

Insider Reports Filed by Mark A. Kay

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000089924322036306-kay-mark-a-2022-11-16 LogicBio Therapeutics, Inc. 16 Nov 2022 4 $0 4 Director 17 Nov 2022, 20:14
/report/000120919122038241-kay-mark-a-2022-06-17 LogicBio Therapeutics, Inc. 17 Jun 2022 1 $0 4 Director 21 Jun 2022, 08:15
/report/000120919121042044-kay-mark-a-2021-06-18 LogicBio Therapeutics, Inc. 18 Jun 2021 1 $0 4 Director 21 Jun 2021, 16:39
/report/000120919121040431-kay-mark-a-2021-06-11 LogicBio Therapeutics, Inc. 11 Jun 2021 1 $0 4 Director 14 Jun 2021, 20:00